Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Mouse anti-Human IgA (Heavy chain) Secondary Antibody, Invitrogen™
Mouse Monoclonal Secondary Antibody
Supplier: Thermo Scientific MA180150
Description
Mouse anti Human IgA heavy chain antibody, clone Mc24-2E11 recognizes human immunoglobulin alpha heavy chains. No cross reactivity observed with IgG, IgM or free kappa and lambda light chains.
Anti-Human secondary antibodies are affinity-purified antibodies with well-characterized specificity for human immunoglobulins and are useful in the detection, sorting or purification of its specified target. Secondary antibodies offer increased versatility enabling users to use many detection systems (e.g. HRP, AP, fluorescence). They can also provide greater sensitivity through signal amplification as multiple secondary antibodies can bind to a single primary antibody. Most commonly, secondary antibodies are generated by immunizing the host animal with a pooled population of immunoglobulins from the target species and can be further purified and modified (i.e. immunoaffinity chromatography, antibody fragmentation, label conjugation, etc.) to generate highly specific reagents.Specifications
Human IgA (Heavy chain) | |
Monoclonal | |
1 mg/mL | |
TBS with 0.09% sodium azide; pH 7.4 | |
Reduced and alkylated human IgA. | |
200 μg | |
Secondary | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
IgG1 |
ELISA, Immunohistochemistry (Frozen), Immunoprecipitation, Western Blot | |
Mc24-2E11 | |
Unconjugated | |
Mouse | |
Protein A | |
RUO | |
Human | |
Liquid |
Safety and Handling
WARNING: Reproductive Harm - www.P65Warnings.ca.gov
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?
Provide Content Correction